A nationally-published, award-winning journalist, Alex Biese joined the CURE team as an assistant managing editor in April 2023. Prior to that, Alex's work was published in outlets including the Chicago Sun-Times, MTV.com, USA TODAY and the Press of Atlantic City. Alex is a member of NLGJA: The Association of LGBTQ+ Journalists, and also performs at the Jersey Shore with the acoustic jam band Somewhat Relative.
FDA Approves Braftovi and Mektovi for Some Patients with Metastatic NSCLC
October 12th 2023Braftovi (encorafenib) with Mektovi (binimetinib) has been approved for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, the agency announced on Wednesday evening.
‘The Complete Guide to Breast Reconstruction’ Author Empowers Patients With Information
October 5th 2023Now in its fifth edition, “The Complete Guide to Breast Reconstruction: Choosing the Best Options After Your Mastectomy” by two-time breast cancer survivor Kathy Steligo offers patients comprehensive, up-to-date information.
Experts Indifferent About Drug Use Among Patients With Cancer With Short Prognoses
September 25th 2023“If prognosis is just weeks to months and pain is well-controlled, (I’m) not sure I really care about other illicit substance use,” said one member of a panel evaluating opioid management approaches among patients experiencing advanced cancer-related pain and using nonmedical stimulants.
Masofaniten Plus Xtandi Has Potential Clinical Benefits for Patients With mCRPC
September 24th 2023The second phase of a study evaluating androgen receptor inhibitor masofaniten combined with antiandrogen Xtandi for the treatment of patients with metastatic castration-resistant prostate cancer has been launched.
The Evolving Psychosocial Needs of Young Patients With Cancer and Their Families
September 15th 2023As part of its Speaking Out video series, CURE spoke with Hannah-Lise Schofield of the Children’s Hospital of Philadelphia about the psychosocial needs of young patients with cancer and their families as well as how those needs change over time.
‘Incredible Advancements in Immunotherapy’ and Other Advancements in Pediatric Cancer Research
September 15th 2023As part of its Speaking Out video series, CURE spoke with Bruce L. Levine of the University of Pennsylvania Perelman School of Medicine about advancements in treatments for pediatric cancer.
Why Cellular Therapy and Gene Therapy Represent ‘The Next Pillar of Medicine’ for Patients
September 15th 2023As part of its Speaking Out video series, CURE spoke Bruce L. Levine of the University of Pennsylvania Perelman School of Medicine about CAR-T cell therapy, what it means for young patients with cancer and what new horizons it has revealed for treatment.
‘Never Give Up’: How Families of Young Patients With Cancer Can Seek The Best Treatment
September 15th 2023As part of its Speaking Out video series, CURE spoke with Tom Whitehead, co-founder and president of the Emily Whitehead Foundation, about the process of seeking treatment and what resources are available for young patients with cancer and their families.